You are here: Industry Insights > CSIR

News List

CSIR, Laxai Life Sciences get DCGI nod for clinical trials of Colchicine on COVID-19 patients expresspharma
June 15, 2021
Enrolment of patients has already begun at multiple sites across India and the trial is likely to be completed in the next 8-10 weeks.
CSIR-IICT, Lee Pharma sign agreement to produce 2-D expresspharma
June 10, 2021
Lee Pharma will manufacture and commercialise the 2-DG sachets from their formulation facility located at SEZ, Duvvada, Visakhapatnam, Andhra Pradesh.
NMPB and CSIR-NBRI sign MoU for promoting cultivation and production of medicinal plants expresspharma
June 08, 2021
Through this collaboration, NMPB will support CSIR-NBRI in carrying out the potential medicinal plant species with high commercial value for germplasm collection/conservation and establishment of nursery and seed banks/gene banks.
CSIR and Laxai Life Sciences begin phase II trial of niclosamide drug to treat COVID-19 expresspharma
June 08, 2021
Niclosamide has been extensively used in the past for treating tapeworm infection in adults as well as children.
Scientific community rose to occasion when COVID-19 hit country: Vardhan expresspharma
March 02, 2021
The three-day event from March 1-3 will showcase the strength and opportunities of the India's biotechnology sector at national level and to the global community.
Expect to commercialise vaccine facility by April-May 2021: Aurobindo Pharma expresspharma
December 01, 2020
It is investing around Rs 275 crores on the facility to produce vaccines for the treatment of various viral diseases including COVID-19.
CSIR announces Shanti Swarup Bhatnagar Prize 2020 to 14 scientists expresspharma
September 28, 2020
The scientists work in renowned national research and academic institutions across the country.
CSIR and Mylan in partnership to develop therapeutic options for COVID–19 management expresspharma
September 24, 2020
The application for the clinical trials has been submitted to DCGI for regulatory approval.
CSIR and Aurobindo Pharma to collaborate for COVID-19 vaccine development expresspharma
September 16, 2020
DBT is also supporting Aurobindo Pharma’s COVID-19 vaccine development through its wholly-owned US subsidiary Auro Vaccines, under the National Biopharma Mission.
CSIR seeks regulatory nod for clinical trials using combination of antivirals and HDTs against COVID-19 expresspharma
July 08, 2020
It is to determine safety and efficacy of three combination drugs (Favipiravir+Colchicine, Umifenovir+Colchicine and Nafamostat+5-ALA) and a control arm with the standard of care in COVID-19 patients.

Previous page 1 2 Next page